Phosphorylated p38, a negative prognostic biomarker, complements TNM staging prognostication in colorectal cancer

Epithelial–mesenchymal transition biomarkers and support vector machine guided model in preoperatively predicting regional lymph node metastasis for rectal cancer

(2012) X-J Fan et al.   BRITISH JOURNAL OF CANCER

Molecular Prognostic Prediction for Locally Advanced Nasopharyngeal Carcinoma by Support Vector Machine Integrated Approach

(2012) Xiang-Bo Wan et al.   PLoS One

Irinotecan induces senescence and apoptosis in colonic cells in vitro

(2012) Emil Rudolf et al.   TOXICOLOGY LETTERS

2010 Staging System for Colon and Rectal Carcinoma

(2011) J. Milburn Jessup et al.   ANNALS OF SURGICAL ONCOLOGY

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

P38MAPK is a major determinant of the balance between apoptosis and autophagy triggered by 5-fluorouracil: implication in resistance

(2011) M A de la Cruz-Morcillo et al.   ONCOGENE

Expression of KITENIN in human colorectal cancer and its relation to tumor behavior and progression

(2011) Seok Lee et al.   PATHOLOGY INTERNATIONAL

AKT signaling pathway activated by HIN-1 methylation in non-small cell lung cancer

(2011) Yuanzi Yu et al.   TUMOR BIOLOGY

Targeting the p38 MAPK Pathway Inhibits Irinotecan Resistance in Colon Adenocarcinoma

(2010) S. Paillas et al.   CANCER RESEARCH

p38 Mitogen-Activated Protein Kinase-Driven MAPKAPK2 Regulates Invasion of Bladder Cancer by Modulation of MMP-2 and MMP-9 Activity

(2010) B. Kumar et al.   CANCER RESEARCH

Serologic Antienzyme Rate of Epstein-Barr Virus DNase-Specific Neutralizing Antibody Segregates TNM Classification in Nasopharyngeal Carcinoma

(2010) Jie Xu et al.   JOURNAL OF CLINICAL ONCOLOGY

Colorectal cancer

(2010) David Cunningham et al.   LANCET

Interaction of Snail and p38 mitogen-activated protein kinase results in shorter overall survival of ovarian cancer patients

(2010) Susanne Hipp et al.   VIRCHOWS ARCHIV

Stage II/III rectal cancer with intermediate response to preoperative radiochemotherapy: Do we have indications for individual risk stratification?

(2010) Thilo Sprenger et al.   World Journal of Surgical Oncology

KRAS Mutational Status as a Predictor of Epidermal Growth Factor Receptor Inhibitor Efficacy in Colorectal Cancer

(2009) Roy D Baynes et al.   AMERICAN JOURNAL OF THERAPEUTICS

Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on Individual Patient Data From 20,898 Patients on 18 Randomized Trials

(2009) Daniel Sargent et al.   JOURNAL OF CLINICAL ONCOLOGY

Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial

(2009) Thierry André et al.   JOURNAL OF CLINICAL ONCOLOGY

Wild-TypeBRAFIs Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer

(2008) Federica Di Nicolantonio et al.   JOURNAL OF CLINICAL ONCOLOGY

Wild-TypeKRASIs Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer

(2008) Rafael G. Amado et al.   JOURNAL OF CLINICAL ONCOLOGY

Regulation of gamma-H2AX and securin contribute to apoptosis by oxaliplatin via a p38 mitogen-activated protein kinase-dependent pathway in human colorectal cancer cells

(2008) Shu-Jun Chiu et al.   TOXICOLOGY LETTERS